Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis.
Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
Axonal pathology in Krabbe's disease: The cytoskeleton as an emerging therapeutic target.
Effectiveness of intramuscular injections of botulinum toxin in the treatment of disabling cerebellar tremor of the hand.
Evolution of MRI abnormalities in paediatric acute disseminated encephalomyelitis.
Vitamin D modulates different IL-17-secreting T cell subsets in multiple sclerosis patients.
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
Pharmaceutical Approval Update.
Update on infections with human herpesviruses 6A, 6B, and 7.
Oxidative stress-related biomarkers in multiple sclerosis: a review.
Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Complex coacervation for the development of composite edible films based on LM pectin and sodium caseinate.
Task-dependent deterioration of balance underpinning cognitive-postural interference in MS.
Neuromyelitis optica spectrum disorders in children and adolescents.
Corrigendum.
Preferential conduction block of myelinated axons by nitric oxide.
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree.
Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
Acute Disseminated Encephalomyelitis Following Immunization with Human Papillomavirus Vaccines.
[Symptoms of obsessive-compulsive disorder in neurological diseases].
Neuroleptic Malignant Syndrome Associated with Refractory Acute Disseminated Encephalomyelitis.
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NFκB.
Global progress in the control of viral hepatitis and acceptable delay in Hepatitis B immunization.
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Alterations of the human gut microbiome in multiple sclerosis.

Pages